NIH Launches $2 Million Prize Competition for Fetal Diagnostic Technologies
Desired fetal diagnostic tech from the NIH includes wearable devices, in vitro diagnostic tests, imaging devices, and sensor technologies.
Category: Womens Health
Womens Health
Latest
Womens Health
Latest
What Self-Sampling for Women’s Health Testing Means for Labs
The enhancement of women’s health is a focal point for many companies, and is projected to reach $75.1 billion by 2025.
Womens Health
Latest
Devyser’s Prenatal Chromosome Test Gets IVDR Certification
Devyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Juno Hazel Increases Accessiblity of Non-Invasive Prenatal Screening
Juno Diagnostics has announced the launch of Juno Hazel, a non-invasive prenatal screening (NIPS) solution.
Read More
FDA Approves Roche CDx Assay to Target Treatment for Ovarian Cancer Patients
The FDA approved Roche’s companion diagnostic test to aid in identifying epithelial ovarian cancer patients eligible for targeted treatment.
Read More
Sera Prognostics Predicts Clinical Utility of Preterm Test-and-Treat Strategies
Sera Prognostics’ blood-based test offers individualized risk prediction for spontaneous preterm birth in asymptomatic singleton pregnancies.
Read More
Biomarkers Could Point to Preclampsia Risk
Cedars-Sinai investigators have found that a specific imbalance of two placental proteins could predict preeclampsia risk.
Read More
Fetal Fraction Enrichment for NIPT
Diagnostic screening for Down’s Syndrome during pregnancy was difficult until the development of an NIPT fetal fraction test.
Read More
New Ovarian Cancer Detection Tech Developed at Wilmot
New tech can capture stray ovarian cancer cells from a blood test and predict cancer in those who have a lesion or cyst in the pelvic region.
Read More
Women’s Heart Centers Improve Accurate Diagnoses & Outcomes
Declines in cardiovascular disease death rates stalled for mid-life women compared to men, suggesting sex-specific approaches may be needed.
Read More
AACC Updates Guidance for Point-of-Care Tests for Fertility & Reproductive Health
AACC has issued a new guidance document with expert recommendations for performing point-of-care tests for fertility and reproductive health.
Read More
Genetic Testing Before Pregnancy Detects Up to Half of the Risk
In many parts of the U.S., broad genetic testing is offered to prospective parents and is usually also recommended in early pregnancy.
Read More
Healthcare Org Uses Innovative Tool to Diagnose Coronary Microvascular Dysfunction
The MedStar Heart & Vascular Institute’s program uses the Coroventis CoroFlow Cardiovascular System for CMD diagnosis.
Read More
Hera Biotech Closes $1.9 Million Seed Raise for Endometriosis Diagnostic Test
Hera Biotech closed a $1.9 million seed financing round to support the commercialization of its non-surgical endometriosis diagnostic test.
Read More
DotLab Gets Three Granted Patents for Non-Invasive Endometriosis Tests
DotLab announced that the U.S. Patent and Trademark Office has granted three key patents for the company’s endometriosis tests.
Read More
Nanopath Secures $10M to Develop POC Diagnostics for Women’s Health
Nanopath will develop & commercialize a biosensing platform that aims to transform how women’s pelvic & gynecologic infections are diagnosed.
Read More
Change of Venue: How Oklahoma Successfully Relocated Its Public Health Laboratory
The Oklahoma State Public Health Laboratory transferred to a new facility in the midst of the COVID-19 crisis.
Read More
Preeclampsia Linked to Increased Markers of Brain Damage, Inflammation
Researchers found that women with a history of severe preeclampsia have more markers linked to brain cell damage and inflammation.
Read More